Transforming growth factor-beta type II receptor confers tumor suppressor activity in murine renal carcinoma (Renca) cells

Urology

Volumn 54, Issue 1, 1999, Pages 164-170

  Engel, Jason D ^b   Kundu, Shilajit D ^b   Yang, Tony ^b   Lang, Sharon ^b   Goodwin, Shannon ^b   Janulis, Lynn ^b   Cho, Jin Seon ^b   Chang, Jay ^b   Kim, Seong Jin ^b   Lee, Chung ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; NEUTRALIZING ANTIBODY; THYMIDINE; TRANSFORMING GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRITIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CARCINOGENICITY; CARCINOMA CELL; CONTROLLED STUDY; EXPRESSION VECTOR; GENETIC TRANSFECTION; GROWTH INHIBITION; KIDNEY CARCINOMA; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; RETROVIRUS; TUMOR SUPPRESSOR GENE; TUMOR XENOGRAFT;

ANIMALS; CARCINOMA, RENAL CELL; CELL DIVISION; MICE; MICE, NUDE; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA, MESSENGER; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0033168833     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(99)00093-X     Document Type: Article

References (21)

1. Massague J: The transforming growth factor-β. Annu Rev Cell Biol 6: 597-641, 1990.
2. Moses HL, Yang EY, and Pietenpol JA: TGF-β stimulation and inhibition of cell proliferation: new mechanistic insights. Cell 63: 245-247, 1990.
3. Roberts AB, and Sporn MB (Eds): Peptide Growth Factors and Their Receptors. Heidelberg, Springer-Verlag, 1991, pp 419-472.
4. Barrack ER: TGFβ in prostate cancer: a growth inhibitor that can enhance tumorigenicity. Prostate 31: 61-70, 1997.
5. Huang F, Newman E, Theodorescu D, et al: Transforming growth factor β1 (TGF-β1) is an autocrine positive regulator of colon carcinoma U9 cells in vivo as shown by transfection of a TGF-β1 antisense expression plasmid. Cell Growth Differ 6: 1635-1642, 1995.
6. Sun L, and Chen C: Expression of transforming growth factor β type III receptor suppressed tumorigenicity of human breast cancer MDA-MB-231 cells. J Biol Chem 272: 25367-25372, 1997.
7. Wrana JL, Attisano L, Carcamo J, et al: TGF-β signals through a heteromeric protein kinase receptor complex. Cell 71: 1003-1014, 1992.
8. Wrana JL, Attisano L, Wieser R, et al: Mechanism of activation of the TGF-β receptor. Nature 370: 341-347, 1994.
9. Hoosein NM, McKnight MK, Levine AE, et al: Differential sensitivity of subclasses of human colon carcinoma cell lines to the growth inhibitory effects of transforming growth factor-β1. Exp Cell Res 181: 442-453, 1989.
10. Manning AM, Williams AC, Game SM, et al: Differential sensitivity of human colonic adenoma and carcinoma cells to transforming growth factor β (TGF-β): conversion of an adenoma cell line to a tumorigenic phenotype is accompanied by a reduced response to the inhibitory effects of TGF-β. Oncogene 6: 1471-1476, 1991.
11. Markowitz S, Meyeroff L, Parsons R, et al: Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science 268: 1336-1338, 1995.
12. Inagaki M, Moustakas A, Lin HY, et al: Growth inhibition by transforming growth factor β (TGF-β) type I is restored in TGF-β-resistant hepatoma cells after expression of TGF-β receptor type II cDNA. Proc Natl Acad Sci USA 90: 5359-5363, 1993.
13. Park K, Kim SJ, Bang YJ, et al: Genetic changes in the transforming growth factor β (TGF-β) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-β. Proc Natl Acad Sci USA 91: 8772-8776, 1994.
14. Chang J, Park K, Bang YJ, et al: Expression of transforming growth factor β type 11 receptor reduces tumorigenicity in human gastric cancer cells. Cancer Res 57: 2856-2859, 1997.
15. Myeroff LL, Parsons R, Kim SJ, et al: A transforming growth factor β receptor type 11 gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. Cancer Res 55: 5545-5547, 1995.
16. Kim IY, Ahn HJ, Zelner DJ, et al: Loss of expression of transforming growth factor-β type I and type II receptors correlates with tumor grade in human prostate cancer lines. Clin Cancer Res 2: 1255-1261, 1996.
17. Ramp U, Jaquet K, Reinecke P, et al: Acquisition of TGF-β1 resistance: an important progression factor in human renal cell carcinoma. Lab Invest 76: 739-749, 1997.
18. Kundu SD, Kim IY, Zelner D, et al: Absence of expression of transforming growth factor-β type 11 receptor is associated with an aggressive growth pattern in a murine renal carcinoma cell line, Renca. J Urol 160: 1883-1888, 1998.
19. Kim IY, Kim J, Zelner DJ, et al: Transforming growth factor β-1 is a mediator of androgen-regulated growth arrest in an androgen-responsive prostatic cancer cell line, LNCaP. Endocrinology 137: 991-999, 1996.
20. Janik P, Briand P, and Hartmann NR: The effects of estrogen-progesterone treatment on cell proliferation kinetics of hormone dependent GR mouse mammary tumors. Cancer Res 35: 3698-3704, 1975.
21. Steele RED, and Torrie JH (Eds): Principles and Procedures of Statistics. New York, McGraw-Hill, 1960, pp 67-87.